Heuron Co.

Heuron Co.

Medical Imaging & Radiology

About Heuron Co.

Heuron Co. is a South Korean medical imaging AI company that develops computer-aided diagnostic software for healthcare providers. The company's flagship products include Heuron IPD, an AI-powered diagnostic aid for neurodegenerative Parkinson's disease that analyzes nigrosome 1 MR images, and Heuron ICH, a radiological triage and notification system for intracranial hemorrhage detection. Heuron's solutions are designed to assist medical professionals in streamlining clinical workflows and improving diagnostic accuracy through objective, AI-driven insights. The company's technology analyzes medical imaging data combined with clinical information to support healthcare decision-making. Heuron IPD has demonstrated high performance with sensitivity ≥93.3% and specificity ≥95% in internal evaluations. The company maintains strict compliance with healthcare data protection regulations and deploys its solutions through cloud infrastructure. Heuron serves hospitals, radiology departments, and neurology specialists, providing tools that integrate into existing clinical workflows to enhance diagnostic capabilities and patient care outcomes.

Clinical Focus

Medical conditions and clinical areas addressed by Heuron Co..

Neurodegenerative Parkinson's diseaseIntracranial hemorrhage (ICH)

Who It Serves

HospitalsRadiology departmentsNeurology specialistsMedical professionals

Company Details

Headquarters
Seoul, South Korea

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Security & Compliance

ISO 14971
Last updated Jun 30, 2026

Similar Companies in this Market

View all 189
A2z Radiology Ai

A2z Radiology Ai

AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.

Adas3D Medical S.L

Adas3D Medical S.L

11-50 employees

Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.

AEYE Health

AEYE Health

11-50 employees

AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.

Agfa HealthCare N.V.

Agfa HealthCare N.V.

AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.

AI4MedImaging Medical Solutions

AI4MedImaging Medical Solutions

AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.

Aidence

Aidence

Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.

Aidoc

Aidoc

growth · 350 employees

Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.

Aikenist Technologies Pvt Ltd

Aikenist Technologies Pvt Ltd

21-100 employees

Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.